2-{[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfanyl}-1H-benzimidazole monohydrate: a monoclinic polymorph
The title compound, C16H14F3N3OS·H2O, which had been previously characterized in the space group P-1 [Ren et al. (2011). Acta Cryst. E67, o270], has now been crystallized from 1-propanol in the monoclinic form in the space group P21/c. While the triclinic form is a Z′ = 2...
Main Authors: | Yu-Feng Chen, Jin-Yao Chen, Ming-Huang Hong, Jie Lu, Guo-Bin Ren |
---|---|
Format: | Article |
Language: | English |
Published: |
International Union of Crystallography
2012-07-01
|
Series: | Acta Crystallographica Section E |
Online Access: | http://scripts.iucr.org/cgi-bin/paper?S1600536812022131 |
Similar Items
-
2-{[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfanyl}-1H-benzimidazole monohydrate
by: Guo-Bin Ren, et al.
Published: (2011-02-01) -
2-{[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfanyl}-1H-benzimidazole propan-2-ol monosolvate: a second monoclinic polymorph
by: Jin-Ju Ma, et al.
Published: (2012-07-01) -
1-(4-Methylphenylsulfonyl)-2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfanyl}-1H-1,3-benzimidazole
by: N. K. Lokanath, et al.
Published: (2013-12-01) -
2-Benzylsulfanyl-3-(2,2,2-trifluoroethoxy)pyridine
by: Tao Dong, et al.
Published: (2010-12-01) -
8-(2,2,2-Trifluoroethoxy)quinolinium perchlorate–8-(2,2,2-trifluoroethoxy)quinoline (1/1)
by: Jun Wu, et al.
Published: (2011-05-01)